Speaker Profile
Ph.D., Director, Eli Lilly &
Biography
Sean Bedingfield, PhD, is Director of Genetic Medicine at Eli Lilly and Company, where he leads research on non-viral delivery technologies for genetic medicines. His team develops approaches to reach tissues beyond the liver, integrating targeted delivery, formulation science, and emerging platforms for RNA therapeutics, gene editing, and gene therapy. His work spans early discovery, platform development, external collaborations, and evaluation of new technologies, with a focus on overcoming delivery barriers that limit clinical translation. Before joining Lilly, he served as a technical lead in business development at Pendant Biosciences. He earned his PhD in Biomedical Engineering from Vanderbilt University and has published research in RNA delivery, protein engineering, intracellular assays, and nanomedicine.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
